Clinical Update from the Ongoing Phase 2 Trial of PRV111, the First Non-Surgical Therapy in Development for Early-Stage Oral Cancer

Privo Technologies today announced results from the CLN-004 Phase 2 (Cohort 1) trial evaluating PRV111, a nanoengineered, ...